Navigation Links
Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards
Date:6/20/2011

NEW YORK, June 20, 2011 /PRNewswire/ -- Merisel, Inc. (OTC: MSEL) operating under its principal brand Coloredge New York - Los Angeles, a leading provider of visual communications and brand imaging solutions, was awarded "Business Turnaround of the Year" last night at the 9th Annual American Business Awards Ceremony, in recognition of its agility to adapt, grow, and maintain its commitment to delivering solid results, despite prevailing economic turbulence.

The American Business Awards, part of The Stevie Awards program, honors the achievements and contributions of US-based businesses and their employees.  Awards were presented in over 40 categories and more than 2,800 entries were received from organizations of all sizes in virtually every industry.  Merisel itself was a finalist for ten awards in seven categories, including "Best Overall Company of the Year," "Business Innovation of the Year," and "Turnaround Executive of the Year."

The distinction of "Business Turnaround of the Year" is awarded to the company that showed significant operational and financial improvement in 2010 over 2009. The winning nomination stated:

[Merisel] ended 2009 with a 26% decline in net sales vs. 2008 and an operating loss of $9.3 million (adjusted to exclude one-time non-cash expenses).  We finished 2010 with 15.9% year-on-year revenue growth and strong operating income of $1.5 million, resulting in a turnaround of $10.8 million.  Undoubtedly, [Merisel] achieved these results through persistent adherence to our three core tenets:  Consistently creating superior value for our customers, focusing our operations on efficiency, and instilling a culture defined by high-performance and excellence.

Upon accepting the award at last night's ceremony, Donald R. Uzzi, Chairman & CEO, stated, "We are honored to receive this prestigious recognition by The Stevie Awards for our diligent per
'/>"/>

SOURCE Merisel, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
2. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
3. Elanco Announces Acquisition of Posilac(R) Dairy Business
4. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
5. Chiltern Early Phase: Fully Integrated and Business Ready
6. Insulet Appoints Bill Arthur as Vice President of Business Development
7. Therapure Biopharma Inc. opens for business with first client contracts
8. Ohio Recognized as National Leader for Business Development and Job Creation
9. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
10. Cyberonics Provides Update on Business Operations Following Hurricane Ike
11. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent ... viruses is the Epstein Barr Virus (EBV), and one of ... a chronic inflammatory disease that destroys the body’s joints. As ... have high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 As pet owners drew ... doubt many of them wrote: "Take better care of my furry ... even designer clothes and top-brand carrying cases to take the little ... parents might also feel compelled to buy some pricey toys at ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... life sciences industry faces a host of policy ... and nationally, SAN FRANCISCO, Jan. 10 ... providing a broad overview of,the productivity of Northern ... science research cluster in the world. To ensure,continued ...
... France, January 10 Transgene,(Euronext Paris: FR0005175080) announces ... its therapeutic vaccine TG4010,(MVA-MUC1-IL2) as an adjunct to ... lung cancer (NSCLC)., This on-going trial is ... assess the efficacy of TG4010 in combination with ...
... BIRMINGHAM, Alabama,Jan. 10 CANTOX HEALTH SCIENCES INC. ... regulatory consulting firm with,specialized expertise in the areas ... Agriculture, Biotech & Consumer Products announces,the launch of ... their,Pharmaceutical & Healthcare Division., For the past ...
Cached Biology Technology:Bioscience Group Warns Policymakers Against Complacency 2Bioscience Group Warns Policymakers Against Complacency 3Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 2Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 3Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division 2
(Date:4/17/2014)... researchers have detected new early-warning signs of the potential ... have far-reaching implications for the diagnosis and treatment of ... million Americans. , "We had not expected to see ... stages," said Ann Elsner, professor and associate dean in ... the study. "We set out to study the early ...
(Date:4/17/2014)... full of wild animals and plant life, but there,s ... churning away in the soil, decomposing organic matter and ... role these fungi play in ecological systems, their identities ... scientists has generated a genetic map of more than ... was published this week in the Proceedings of ...
(Date:4/17/2014)... Modern View of Domestication," a special feature of ... Sciences ( PNAS ) published April 29, raises ... our deep history that most of us take for ... people in many spots around the globe shifted from ... livestock and plants. , It seems so straightforward and ...
Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
... research at the Hebrew University of Jerusalem sheds light ... themselves indefinitely and to differentiate into all types of ... challenge in modern biology, could expedite the use of ... If scientists can replicate the mechanisms that make pluripotency ...
... Calif. As spatial planning is used increasingly to manage ... the best ways to use and refine the various spatial ... of the most common methods, which limit or entirely curtail ... in the early edition of the Proceedings of the ...
... used tiny, artificial fiber scaffolds thousands of times smaller than ... into cartilage, the shock-absorbing lining of elbows and knees that ... 4 in the Proceedings of the National Academy of ... both laboratory and animal models. While the findings are still ...
Cached Biology News:Researchers identify mechanisms that allow embryonic stem cells to become any cell in the human body 2Refining the tool kit for sustainable fisheries 2Refining the tool kit for sustainable fisheries 3Nanoscale scaffolds and stem cells show promise in cartilage repair 2Nanoscale scaffolds and stem cells show promise in cartilage repair 3
... PowerPac basic power supply are used for submerged ... gels. The Mini-Sub cell GT cell includes a ... 7 x 7 cm UV-transparent gel tray with ... mm fixed-height combs (8- and 15-well). The PowerPac ...
... PowerPac basic power supply are used for submerged ... gels. This Model 96 cell includes a buffer ... tray with fluorescent ruler, and a gel caster. ... V, provides output of 10-300 V, 4-400 mA, ...
... The Sub-Cell Model 192 and PowerPac basic power ... of nucleic acids in agarose gels. This Model ... x 15 cm UV-transparent gel tray with fluorescent ... power supply, 100-120 and 220-240 V, provides output ...
... The Sequi-Gen GT and PowerPac 3000 system, ... using a 38 x 30 cm vertical slab ... GT electrophoresis cell, which is capable of separating ... an integral plate chamber (IPC) assembly (IPC and ...
Biology Products: